Rafferty Asset Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Rafferty Asset Management's PRAX Position: Q3 2026 in Review
Rafferty Asset Management increased its Praxis Precision Medicines (PRAX) stake by 61% in Q3 2026, buying an estimated $2.33M and bringing the position to 18,504 shares worth $5.39M. The position accounts for 0.01% of the portfolio, ranked #368.
Rafferty Asset Management first reported a position in PRAX in Q1 2021 and has held it in 14 quarters since. The position peaked at $6.56M in Q4 2025. 337 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Rafferty Asset Management held 18,504 shares of Praxis Precision Medicines worth $5.39M as of Q3 2026.
- Rafferty Asset Management bought 7,034 Praxis Precision Medicines shares in Q3 2026, an estimated $2.33M.
- Praxis Precision Medicines made up 0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #368 holding.
- Rafferty Asset Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 14 quarters since.
- Rafferty Asset Management's Praxis Precision Medicines position peaked at $6.56M in Q4 2025.
- 337 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.